Table 1 Demographic and clinical features of patients from whom tissue and serum samples were collected

From: Identification of macrophage migration inhibitory factor and human neutrophil peptides 1–3 as potential biomarkers for gastric cancer

Tissue samples

 

Serum samples

Age (mean, range)

71.1, 58–81 years

Gastric cancer (n=51)

Male/female

16/5

Age (mean, range)

65.9, 37–87 years

Stage I

4

Male/female

41/10

Stage II

1

Stage I

25

Stage III

4

Stage II

7

Stage IV

12

Stage III

4

  

Stage IV

15

  

H. pylori (mean, range)

41.3, 5.0–138.4

  

Gastric ulcer/gastritis (n=29)

  

Age (mean, range)

40.0, 22–69 years

  

Male/female (n)

17/12

  

H. pylori (mean, range) (U ml−1)

23.4, 4.7–133.4